Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe

Eur J Intern Med. 2023 Jun:112:122-125. doi: 10.1016/j.ejim.2023.02.014. Epub 2023 Feb 13.

Authors

Alfredo Jose Pardo-Cabello¹, Victoria Manzano-Gamero², Juan de Dios Luna³

Affiliations

¹ Department of Internal Medicine, Hospital Universitario San Cecilio, Avda. de la Innovación, s/n, Granada 18016, Spain. Electronic address: alfredoj.pardo.sspa@juntadeandalucia.es.
² Department of Internal Medicine, Hospital Universitario Virgen de las Nieves, Granada, Spain.
³ Department of Biostatistics, Faculty of Medicine, University of Granada, Granada, Spain.

No abstract available

Keywords: Ad26COVS1; Adverse drug reaction; COVID-19 Vaccines; CX-024414; ChAdOx1 nCoV-19; Tozinameran.

Publication types

Letter
Comment

MeSH terms

COVID-19 Vaccines / adverse effects
COVID-19* / prevention & control
Drug-Related Side Effects and Adverse Reactions* / epidemiology
Europe
Humans
Vaccination
Vaccines*

Substances

COVID-19 Vaccines
Vaccines